• IPO proceeds allocation: Out of the ₹80 crore raised from the primary market, ₹60 crore will be used to fully eliminate term loan debt, with the remaining ₹20 crore deployed for plant debottlenecking.
• Export market strategy: Global chemical pricing is gradually recovering due to Chinese capacity curbs, with the company exporting to the US, Europe, and China while maintaining stock depots in Houston, Rotterdam, and Shanghai.
• Capacity utilization target: Utilization at the Mahad facility dropped to around 44% following the addition of two new product streams late in the fiscal year, but management expects total plant utilization to normalize back to 70%–80% this year.
• Product portfolio diversification: The company is expanding into higher-value performance chemicals for lubricant and mining applications, supported by two newly operational pilot plants in Khopoli.
• Capex funding plan: Future capital expenditure and capacity expansions will be predominantly self-funded through internal accruals and cash flows, with bank debt potentially covering only 15% to 20% of unplanned requirements.